This isn't a very clear cut data set.
However, it isn't doom n gloom. rather, they showed a significant effect on non-inflammatory lesions in both cohorts. the secondary data readout.
If just looking at the AUS data, there's a significant effect in both inflammatory and non-inflammatory lesions.
They need to clarify the placebo and vehicle, I don't really understand how a placebo effect can be so substantial.
safety profile is good.
it works. just not as well in inflammatory lesions as we may have hoped across both Australian and American cohorts.....
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3, page-195
-
- There are more pages in this discussion • 208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
0.015(4.55%) |
Mkt cap ! $624.4M |
Open | High | Low | Value | Volume |
32.5¢ | 35.0¢ | 32.3¢ | $2.184M | 6.494M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 38963 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 34769 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 38963 | 0.340 |
3 | 131100 | 0.335 |
8 | 216172 | 0.330 |
3 | 261000 | 0.325 |
10 | 437414 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 34769 | 1 |
0.350 | 178814 | 5 |
0.355 | 21000 | 2 |
0.360 | 93520 | 6 |
0.365 | 201920 | 5 |
Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |